| The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation A Kosti, PR De Araujo, WQ Li, GDA Guardia, J Chiou, C Yi, D Ray, ... Genome biology 21, 1-32, 2020 | 59 | 2020 |
| Epigenetic reprogramming as a key contributor to melanocyte malignant transformation F Molognoni, AT Cruz, FM Meliso, AS Morais, CF Souza, P Xander, ... Epigenetics 6 (4), 450-464, 2011 | 48 | 2011 |
| RNA processing as an alternative route to attack glioblastoma F Marcelino Meliso, CG Hubert, PA Favoretto Galante, LO Penalva Human genetics 136, 1129-1141, 2017 | 43 | 2017 |
| Epigenetic modulations in activated cells early after HIV-1 infection and their possible functional consequences JT Maricato, MN Furtado, MC Takenaka, ERM Nunes, P Fincatti, ... PLoS One 10 (4), e0119234, 2015 | 28 | 2015 |
| SIRT1 regulates Mxd1 during malignant melanoma progression FM Meliso, D Micali, CT Silva, TS Sabedot, SG Coetzee, A Koch, ... Oncotarget 8 (70), 114540, 2017 | 18 | 2017 |
| The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes RAS Barreiro, GDA Guardia, FM Meliso, X Lei, WQ Li, A Savio, ... RNA biology 20 (1), 311-322, 2023 | 2 | 2023 |
| A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis R Guarischi-Sousa, JE Kroll, A Bonaldi, PM Pierry, D Villela, CA Souza, ... Diagnostics 13 (21), 3293, 2023 | | 2023 |
| HRD-One: CLINICAL VALIDATION AND PERFORMANCE ASSESSMENT. Comparison between Myriad’s myChoice®, SOPHiA GENETICS® SOPHiA Homologous Recombination Solution and AmoyDx® HRD Focus … R Guarischi Sousa, JE Kroll, A Bonaldi, PM Pierry, LG de Almeida, ... medRxiv, 2023.03. 28.21264560, 2023 | | 2023 |
| Contribution of aberrant splicing mechanisms in glioblastoma development. FM Meliso, L Penalva, PA Favoretto Galante CLINICAL CANCER RESEARCH 24 (1), 31-32, 2018 | | 2018 |
| Abstract A24: Contribution of aberrant splicing mechanisms in glioblastoma development FM Meliso, L Penalva, PAF Galante Clinical Cancer Research 24 (1_Supplement), A24-A24, 2018 | | 2018 |
| SIRT1 regulates Mxd1 throughout melanoma progression FM Meliso, D Micali, CT Silva, TS Sabedot, SG Coetzee, A Koch, ... Cancer Research 77 (13_Supplement), 2413-2413, 2017 | | 2017 |
| Papel de sirt1 no estabelecimento de marcas epigenéticas aberrantes associadas à transformação maligna de melanócitos FM Meliso Universidade Federal de São Paulo (UNIFESP), 2015 | | 2015 |
| DNA sequences differentially associated with Sirt1 and Dnmt3b during melanoma progression F Marcelino Meliso, CT da Silva, S Coetzee, T Sarraf Sabedot, ... Cancer Research 75 (15_Supplement), 4767-4767, 2015 | | 2015 |
| miR-138 and its role in melanoma progression AT da Cruz, A Hunger, AS Morais, FM Meliso, MG Jasiulionis Cancer Research 72 (8_Supplement), 3167-3167, 2012 | | 2012 |
| Effect of epigenetic drugs on melanocytes and melanoma cell lines phenotype and aggressiveness F Molognoni, AC Monteiro, AS Morais, CF Souza, AT Cruz, FM Melisso, ... Cancer Research 71 (8_Supplement), 2004-2004, 2011 | | 2011 |
| Epigenetic reprogramming associated with melanocyte malignant transformation induced by sustained stress condition AT Cruz, CF Souza, AS Morais, FF Costa, P Xander, FM Melisso, ... Cancer Research 70 (8_Supplement), 4892-4892, 2010 | | 2010 |
